脑卒中早期上肢活动能力简版评估(ARAT-2)的效度评价
本研究纳入117例首次脑卒中且上肢功能受损的成人,在发病后3天、10天和4周时用ARAT-2、原始ARAT与FMA-UE评估上肢活动能力与运动功能。ARAT-2与其余量表相关性高(r=0.92–0.97),各时间点变化均具统计学意义(效应量r=0.31–0.48),但存在地板效应,且天花板效应比ARAT和FMA-UE更早出现。结论认为ARAT-2是有效、反应性好的简版评估,适用于脑卒中急性期,但达到最高分后需补充其他工具。
要点
- ARAT-2与ARAT、FMA-UE相关性高(r=0.92–0.97),可作为急性期简版上肢活动能力评估。
- ARAT-2在各时间点变化均有统计学意义(效应量r=0.31–0.48),反应性可接受。
- ARAT-2在各时间点均见地板效应,天花板效应比ARAT和FMA-UE更早出现,达最高分后需补充评估。
核心结论
- ARAT-2似乎是有效且反应性好的上肢活动能力简版评估,适用于脑卒中急性期;但达到最高分后需用其他工具补充。
研究设计与样本
- 前瞻性纵向队列研究,纳入117例首次脑卒中且上肢功能受损的成人,为非选择性队列。
- 在发病后3天、10天和4周时用ARAT与FMA-UE评估活动能力与运动功能,并分析ARAT-2的并发效度、反应性及地板和天花板效应。
主要发现
- ARAT-2与其他评估量表相关性高(r=0.92–0.97)。
- ARAT-2在所有时间点之间的变化均具统计学意义(效应量r=0.31–0.48)。
- ARAT和FMA-UE变化的效应量为0.44–0.53。
- ARAT-2与ARAT一样在所有时间点均出现地板效应。
- ARAT-2比ARAT和FMA-UE更早达到天花板效应。
关键数值与推荐
- ARAT-2与ARAT、FMA-UE的相关系数为r=0.92–0.97。
- ARAT-2各时间点变化的效应量为r=0.31–0.48;ARAT和FMA-UE变化的效应量为0.44–0.53。
临床怎么用
- 脑卒中急性期可用ARAT-2快速评估上肢活动能力,其结果与ARAT、FMA-UE高度一致。
- 评估达最高分后应补充其他工具,以避免天花板效应掩盖进一步的功能变化。
- 因存在地板效应,上肢功能严重受损者早期低分需谨慎解读。
局限性
- 原文未报告研究局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore the concurrent validity, responsiveness, and floor- and ceiling-effects of the 2 items of Action Research Arm Test (ARAT-2) in comparison with the original ARAT and the Fugl-Meyer Assessment for Upper Extremity (FMA-UE) during the first 4 weeks post-stroke. DESIGN: A prospective longitudinal cohort study. SUBJECTS: A non-selected cohort of 117 adults with first-ever stroke and impaired upper extremity function. METHODS: The activity capacity and motor function was assessed with ARAT and FMA-UE at 3 days, 10 days and 4 weeks post-stroke. RESULTS: Correlation between ARAT-2 and the other assessment scales was high (r=0.920.97) and ARAT-2 showed statistically significant changes between all time-points (effect size, r=0.310.48). The effect sizes for the change in ARAT and FMA-UE varied from 0.44 to 0.53. ARAT-2, similarly to ARAT, showed a floor effect at all time-points. The ceiling effect was reached earlier using ARAT-2 than with ARAT and FMA-UE. CONCLUSION: ARAT-2 appears to be valid and a responsive short assessment for upper extremity activity capacity, and suitable for use in the acute stage after stroke. However, when the highest score has been reached, the assessment needs to be complemented with other instruments.
引用
- Kristersson T, Persson HC, Alt Murphy M, et al. Evaluation of a short assessment for upper extremity activity capacity early after stroke. J Rehabil Med. 2019. PMID: 30767025. doi:10.2340/16501977-2534
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。